| Relationship between interferon‐γ, indoleamine 2, 3‐dioxygenase, and tryptophan catabolism MW Taylor, G Feng The FASEB Journal 5 (11), 2516-2522, 1991 | 1362 | 1991 |
| SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases GS Feng, CC Hui, T Pawson Science 259 (5101), 1607-1611, 1993 | 842 | 1993 |
| Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4 LEM Marengère, P Waterhouse, GS Duncan, HW Mittrücker, GS Feng, ... Science 272 (5265), 1170-1173, 1996 | 655 | 1996 |
| Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp‐2 TM Saxton, M Henkemeyer, S Gasca, R Shen, DJ Rossi, F Shalaby, ... The EMBO journal, 1997 | 566 | 1997 |
| Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway M You, DH Yu, GS Feng Molecular and cellular biology 19 (3), 2416-2424, 1999 | 512 | 1999 |
| Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion DH Yu, CK Qu, O Henegariu, X Lu, GS Feng Journal of Biological Chemistry 273 (33), 21125-21131, 1998 | 511 | 1998 |
| The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp MR Kuhne, T Pawson, GE Lienhard, GS Feng Journal of Biological Chemistry 268 (16), 11479-11481, 1993 | 479 | 1993 |
| PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase RJ Chan, GS Feng Blood 109 (3), 862-867, 2007 | 394 | 2007 |
| Shp-2 tyrosine phosphatase: signaling one cell or many GS Feng Experimental cell research 253 (1), 47-54, 1999 | 382 | 1999 |
| Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis EA Bard-Chapeau, S Li, J Ding, SS Zhang, HH Zhu, F Princen, DD Fang, ... Cancer cell 19 (5), 629-639, 2011 | 372 | 2011 |
| SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production H An, W Zhao, J Hou, Y Zhang, Y Xie, Y Zheng, H Xu, C Qian, J Zhou, ... Immunity 25 (6), 919-928, 2006 | 300 | 2006 |
| Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity ZQ Shi, DH Yu, M Park, M Marshall, GS Feng Molecular and cellular biology, 2000 | 295 | 2000 |
| Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. M Kozlowski, I Mlinaric-Rascan, GS Feng, R Shen, T Pawson, ... Journal of Experimental Medicine 178 (6), 2157-2163, 1993 | 293 | 1993 |
| Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism EE Zhang, E Chapeau, K Hagihara, GS Feng Proceedings of the National Academy of Sciences 101 (45), 16064-16069, 2004 | 287 | 2004 |
| Nuclear factor high‐mobility group box1 mediating the activation of Toll‐like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice L Li, L Chen, L Hu, Y Liu, HY Sun, J Tang, YJ Hou, YX Chang, QQ Tu, ... Hepatology 54 (5), 1620-1630, 2011 | 275 | 2011 |
| The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. A Kazlauskas, GS Feng, T Pawson, M Valius Proceedings of the National Academy of Sciences 90 (15), 6939-6943, 1993 | 269 | 1993 |
| Force‐dependent integrin–cytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2 G Von Wichert, B Haimovich, GS Feng, MP Sheetz The EMBO journal, 2003 | 262 | 2003 |
| Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction GS Feng, T Pawson Trends in Genetics 10 (2), 54-58, 1994 | 259 | 1994 |
| Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma L Zheng, W Yang, F Wu, C Wang, L Yu, L Tang, B Qiu, Y Li, L Guo, M Wu, ... Clinical cancer research 19 (19), 5372-5380, 2013 | 256 | 2013 |
| Hepatic transforming growth factor beta gives rise to tumor‐initiating cells and promotes liver cancer development K Wu, J Ding, C Chen, W Sun, BF Ning, W Wen, L Huang, T Han, W Yang, ... Hepatology 56 (6), 2255-2267, 2012 | 240 | 2012 |
